Learn how analytical methodologies can be used to identify RSV pre- and post-fusion proteins for vaccine development.

Inhalon’s inhaled antibody therapy aims to address this need, the release said. Its RSV candidate is part of a more broad effort to develop therapies that deliver therapeutic antibodies directly to ...

The influenza A virus genome consists of eight segments of single-stranded, negative-sense viral RNA, which encode multiple ...

Nasal vaccine devices have the potential to offer more convenient and more effective protection against a variety of viruses.

The results of an observational study from Lund University in Sweden are clear: Up to the age of 2, a more fiber-rich diet ...

Yahoo News provides the latest updates on the spread of bird flu in the U.S. and its effect on rising egg prices and ...

Tokyo, Japan and Cambridge, UK, 14 February 2025 – Nxera Pharma Co., Ltd. (“Nxera” or “the Company”; TSE 4565) provides an update on operational activities and reports its consolidated results for the ...

Corbus Pharmaceuticals has posted the first Western clinical data on its would-be rival to Pfizer’s Padcev. The overall ...

Galderma (SWX:GALD) today announced that the European Commission has approved Nemluvio for both moderate-to-severe atopic ...

More than 50% of patients with systemic lupus erythematosus (SLE) develop lupus nephritis (LN) during the disease, which may ...

This feature is a deep dive into the challenges of defining and treating Difficult-to-Treat Rheumatoid Arthritis (D2T-RA).

Omeros Corporation (Nasdaq: OMER) today announced the availability on its website of materials accompanying two presentations ...